MoonLake Immunotherapeutics (MLTX) stock
MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$11.25−0.48 (-4.09%)
Close on Nov 17, 2026Market cap $957.45MP/E –Yield –
MoonLake Immunotherapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
MoonLake Immunotherapeutics's price to book ratio was 2.2× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 1.3× to 54.7×, with a median of 5.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.2× | −0.7 |
| 2025 | Dec 31, 2025 | 2.9× | −4.0 |
| 2024 | Dec 31, 2024 | 6.9× | +0.6 |
| 2023 | Dec 29, 2023 | 6.3× | +1.7 |
| 2022 | Dec 30, 2022 | 4.5× | – |
See a number that looks wrong?